Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -64.60%869 | 49.52%2.36K | 6.76%9.14K | 78.79%33.59K | 152.24%21K | 2,379.80%2.46K | -83.12%1.58K | 730.55%8.56K | -80.79%18.79K | 174.11%8.33K |
| Selling and administrative expenses | -64.60%869 | 49.52%2.36K | 6.76%9.14K | 78.79%33.59K | 152.24%21K | 2,379.80%2.46K | -83.12%1.58K | 730.55%8.56K | -80.79%18.79K | 174.11%8.33K |
| -General and administrative expense | -64.60%869 | 49.52%2.36K | 6.76%9.14K | 78.79%33.59K | 152.24%21K | 2,379.80%2.46K | -83.12%1.58K | 730.55%8.56K | -80.79%18.79K | 174.11%8.33K |
| Operating profit | 64.60%-869 | -49.52%-2.36K | -6.76%-9.14K | -78.79%-33.59K | -152.24%-21K | -2,379.80%-2.46K | 83.12%-1.58K | -730.55%-8.56K | 80.79%-18.79K | -174.11%-8.33K |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | ||||||||||
| Income before tax | 64.60%-869 | -49.52%-2.36K | -6.76%-9.14K | -78.79%-33.59K | -152.24%-21K | -2,379.80%-2.46K | 83.12%-1.58K | -730.55%-8.56K | 80.79%-18.79K | -174.11%-8.33K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 64.60%-869 | -49.52%-2.36K | -6.76%-9.14K | -78.79%-33.59K | -152.24%-21K | -2,379.80%-2.46K | 83.12%-1.58K | -730.55%-8.56K | 80.79%-18.79K | -174.11%-8.33K |
| Net income continuous operations | 64.60%-869 | -49.52%-2.36K | -6.76%-9.14K | -78.79%-33.59K | -152.24%-21K | -2,379.80%-2.46K | 83.12%-1.58K | -730.55%-8.56K | 80.79%-18.79K | -174.11%-8.33K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 64.60%-869 | -49.52%-2.36K | -6.76%-9.14K | -78.79%-33.59K | -152.24%-21K | -2,379.80%-2.46K | 83.12%-1.58K | -730.55%-8.56K | 80.79%-18.79K | -174.11%-8.33K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 64.60%-869 | -49.52%-2.36K | -6.76%-9.14K | -78.79%-33.59K | -152.24%-21K | -2,379.80%-2.46K | 83.12%-1.58K | -730.55%-8.56K | 80.79%-18.79K | -174.11%-8.33K |
| Diluted earnings per share | 0 | 0 | -6.78%-0.0014 | -0.01 | -730.91%-0.01 | 0 | 0 | -731.41%-0.0013 | 0 | 145.59%0.0016 |
| Basic earnings per share | 0 | 0 | -6.78%-0.0014 | -0.01 | -730.91%-0.01 | 0 | 0 | -731.41%-0.0013 | 0 | 145.59%0.0016 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.